ARTICLE SUMMARY:
Vascular access is the “Achilles Heel” of hemodialysis and has been since the start of this therapy for end-stage renal disease in the 1940s. Thrombosis, infection and loss of patency are ongoing complications that keep patients coming back to vascular surgery for the repair and replacement of vascular access sites. Flow Forward believes it works with the body’s biology to help more patients get the best quality arteriovenous fistulas.
The most fundamental requirement for hemodialysis, the vascular access site through which blood from the body can be cleansed and replaced, has always been the “Achilles Heel” of this therapy for end-stage renal disease.
